115 related articles for article (PubMed ID: 25168689)
1. Demographic clinical and prognostic characteristics of primary ovarian, peritoneal and tubal adenocarcinomas of serous histology--a prospective comparative study.
Schnack TH; Sørensen RD; Nedergaard L; Høgdall C
Gynecol Oncol; 2014 Nov; 135(2):278-84. PubMed ID: 25168689
[TBL] [Abstract][Full Text] [Related]
2. Survival differences in women with serous tubal, ovarian, peritoneal, and uterine carcinomas.
Usach I; Blansit K; Chen LM; Ueda S; Brooks R; Kapp DS; Chan JK
Am J Obstet Gynecol; 2015 Feb; 212(2):188.e1-6. PubMed ID: 25149685
[TBL] [Abstract][Full Text] [Related]
3. Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.
Jordan SJ; Green AC; Whiteman DC; Moore SP; Bain CJ; Gertig DM; Webb PM; ;
Int J Cancer; 2008 Apr; 122(7):1598-603. PubMed ID: 18058817
[TBL] [Abstract][Full Text] [Related]
4. Serous ovarian, fallopian tube and primary peritoneal cancers: a common disease or separate entities - a systematic review.
Sørensen RD; Schnack TH; Karlsen MA; Høgdall CK
Gynecol Oncol; 2015 Mar; 136(3):571-81. PubMed ID: 25615934
[TBL] [Abstract][Full Text] [Related]
5. Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).
Dahm-Kähler P; Borgfeldt C; Holmberg E; Staf C; Falconer H; Bjurberg M; Kjölhede P; Rosenberg P; Stålberg K; Högberg T; Åvall-Lundqvist E
Gynecol Oncol; 2017 Jan; 144(1):167-173. PubMed ID: 27817932
[TBL] [Abstract][Full Text] [Related]
6. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
7. p53 signature and serous tubal in-situ carcinoma in cases of primary tubal and peritoneal carcinomas and serous borderline tumors of the ovary.
Leonhardt K; Einenkel J; Sohr S; Engeland K; Horn LC
Int J Gynecol Pathol; 2011 Sep; 30(5):417-24. PubMed ID: 21804388
[TBL] [Abstract][Full Text] [Related]
8. Demographic Clinical and Prognostic Factors of Primary Ovarian Adenocarcinomas of Serous and Clear Cell Histology-A Comparative Study.
Schnack TH; Høgdall E; Nedergaard L; Høgdall C
Int J Gynecol Cancer; 2016 Jan; 26(1):82-90. PubMed ID: 26569060
[TBL] [Abstract][Full Text] [Related]
9. Incidence and survival of epithelial ovarian, fallopian tube, peritoneal, and undesignated abdominal/pelvic cancers in Sweden 1960-2014: A population-based cohort study.
Leandersson P; Hogberg T; Dickman PW; Malander S; Borgfeldt C
BMC Cancer; 2021 Apr; 21(1):465. PubMed ID: 33902507
[TBL] [Abstract][Full Text] [Related]
10. [Preliminary study on the relationship between tubal intraepithelial carcinoma of the fimbria and pelvic high-grade serous carcinoma].
Liang Y; Chen XD; Lü BJ; Zhou CY; Zhang XF; Shi HY
Zhonghua Fu Chan Ke Za Zhi; 2011 Oct; 46(10):724-8. PubMed ID: 22321343
[TBL] [Abstract][Full Text] [Related]
11. Trends in the incidence of serous fallopian tube, ovarian, and peritoneal cancer in the US.
Liao CI; Chow S; Chen LM; Kapp DS; Mann A; Chan JK
Gynecol Oncol; 2018 May; 149(2):318-323. PubMed ID: 29514737
[TBL] [Abstract][Full Text] [Related]
12. Factors Affecting Short-term Mortality in Women With Ovarian, Tubal, or Primary Peritoneal Cancer: Population-Based Cohort Analysis of English National Cancer Registration Data.
Barclay M; Gildea C; Poole J; Hirschowitz L; Menon U; Nordin A
Int J Gynecol Cancer; 2016 Jan; 26(1):56-65. PubMed ID: 26509852
[TBL] [Abstract][Full Text] [Related]
13. Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Weiss AS; Swisher E; Pennington KP; Radke M; Khasnavis N; Garcia RL; Kilgore MR; Lee MK; Norquist BM
Gynecol Oncol; 2020 Oct; 159(1):214-220. PubMed ID: 32709535
[TBL] [Abstract][Full Text] [Related]
14. Improved survival trends in platinum-resistant patients with advanced ovarian, fallopian or peritoneal cancer treated with first-line paclitaxel/platinum chemotherapy: the impact of novel agents.
Bamias A; Bamia C; Zagouri F; Kostouros E; Kakoyianni K; Rodolakis A; Vlahos G; Haidopoulos D; Thomakos N; Antsaklis A; Dimopoulos MA
Oncology; 2013; 84(3):158-65. PubMed ID: 23296063
[TBL] [Abstract][Full Text] [Related]
15. Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer.
Tanner EJ; Long KC; Feffer JB; Leitao MM; Abu-Rustum NR; Barakat RR; Chi DS; Gardner GJ
Gynecol Oncol; 2013 Jan; 128(1):28-33. PubMed ID: 23017819
[TBL] [Abstract][Full Text] [Related]
16. Comparison between primary peritoneal and epithelial ovarian carcinoma: a population-based study.
Barda G; Menczer J; Chetrit A; Lubin F; Beck D; Piura B; Glezerman M; Modan B; Sadetzki S;
Am J Obstet Gynecol; 2004 Apr; 190(4):1039-45. PubMed ID: 15118638
[TBL] [Abstract][Full Text] [Related]
17. Effect of perioperative venous thromboembolism on survival in ovarian, primary peritoneal, and fallopian tube cancer.
Black D; Iasonos A; Ahmed H; Chi DS; Barakat RR; Abu-Rustum NR
Gynecol Oncol; 2007 Oct; 107(1):66-70. PubMed ID: 17614125
[TBL] [Abstract][Full Text] [Related]
18. Cancer of the ovary, fallopian tube, and peritoneum: a population-based comparison of the prognostic factors and outcomes.
Rottmann M; Burges A; Mahner S; Anthuber C; Beck T; Grab D; Schnelzer A; Kiechle M; Mayr D; Pölcher M; Schubert-Fritschle G; Engel J
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1833-1844. PubMed ID: 28447160
[TBL] [Abstract][Full Text] [Related]
19. Demographic, Clinical, and Prognostic Factors of Ovarian Clear Cell Adenocarcinomas According to Endometriosis Status.
Schnack TH; Høgdall E; Thomsen LN; Høgdall C
Int J Gynecol Cancer; 2017 Nov; 27(9):1804-1812. PubMed ID: 28976447
[TBL] [Abstract][Full Text] [Related]
20. Pattern of retroperitoneal dissemination of primary peritoneum cancer: basis for rational use of lymphadenectomy.
Aletti GD; Powless C; Bakkum-Gamez J; Wilson TO; Podratz KC; Cliby WA
Gynecol Oncol; 2009 Jul; 114(1):32-6. PubMed ID: 19361840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
